M&A
-
礼来收购Verve非深度解析 | 药时代官网首发
本文为原创文章，药时代官网首发。药时代官网每日不定时发布，欢迎广大朋友们关注，充分利用！
-
【Acquisition of Manufacturing Facilities】Seeking pharmaceutical/healthcare CMO/CDMO manufacturing facilities in the United States, Europe, United Kingdom, and Australia. Budget: USD 10 million
If your company is interested in this opportunity, please contact DrugTimes BD team as soon as possible!
-
普米斯宣布与BioNTech达成股权收购协议
热烈祝贺普米斯和BioNTech！
-
The biggest biotech financing of the year has been born! Who will be the next “buyer”?
What will be the fate of this new player in autoimmune diseases in the future?
-
Just finished raising 200 million dollars, and then plan to lay off all the employees?
DrugTimes will continue to pay attention and report timely
-
传奇生物确认收到并购邀约，股价大涨12%，市值近百亿美元，并购邀约引发市场关注
药时代将继续关注，及时报道。
-
Morphic’s stock prices soar by 75%! Eli Lilly invests an additional $3.2 billion in the autoimmune field
DrugTimes will present more reports timely. Please stay tuned
-
股价暴涨75%！礼来32亿美元加码自免领域
未来，国内IBD市场是否也有交易出现？药时代将持续关注
-
Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease
Congratulations to Lilly and Morphic! This acquisition will expand Lilly’s immunology pipeline with oral integrin therapies
-
8 Key Highlights! What Do Global Pharma Industry BD and M&A Trends Forecast for 2024?
Where Pharma is Investing for the Future of Medicine: Biopharma Deal Making in 2024
